| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.011 | 1 |